<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-vaccines-07-00053">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>King</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Treanor</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Fast</surname>
    <given-names>P.E.</given-names>
   </name>
   <name>
    <surname>Wolff</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>L.H.</given-names>
   </name>
   <name>
    <surname>Iacuzio</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Readmond</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Oâ€™Brien</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Mallon</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Highsmith</surname>
    <given-names>W.E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults</article-title>
  <source>J. Infect. Dis.</source>
  <year>2000</year>
  <volume>181</volume>
  <fpage>725</fpage>
  <lpage>728</lpage>
  <pub-id pub-id-type="doi">10.1086/315246</pub-id>
  <pub-id pub-id-type="pmid">10669363</pub-id>
 </element-citation>
</ref>
